Medimetriks Pharmaceuticals, Inc.
Brent Lenczycki is an accomplished financial executive with extensive experience in the pharmaceutical industry. As Chief Financial Officer and co-founder of Medimetriks Pharmaceuticals, Inc. since March 2008, Brent has played a key role in establishing a prominent dermatology company, overseeing corporate finance, business development, and operations. Prior to this, Brent served as Chief Financial Officer at Bradley Pharmaceuticals, Inc. from March 1998 to February 2008, where involvement in the company's turnaround and merger was crucial. Brent's career began at Arthur Andersen & Co. in their Enterprise Group, supporting small public and private companies. Brent holds an MBA in Finance and Management from Tulane University and a Bachelor of Science in Accounting from Saint Joseph's University.
Medimetriks Pharmaceuticals, Inc.
Medimetriks Pharmaceuticals, Inc. is a pharmaceuticals company based out of 383 US-46, Fairfield, New Jersey, United States.